Listing of Equity Shares of HPC Biosciences Limited

• Notice No: 20130318-10
• Notice Date: 18 Mar 2013
• Category: Company related
• Segment: SME

Trading Members of the Exchange are hereby informed that effective from Tuesday, March 19, 2013; the equity shares of HPC Biosciences Limited shall be listed and admitted to dealings on the SME Platform of Exchange in the list of ‘MT’ Group of Securities.  

Name of the company	Securities	Market Lot	Scrip Code
HPC Biosciences Limited	1,59,60,000 equity shares of  Rs. 10/- each fully paid up Distinctive Nos. 1 to 1,59,60,000	4000 Shares	535217
Registered Office: 6 A, 40, Hanuman Road, Connaught Place, New Delhi-110 001 Tel: [phone] Fax: [phone] Email: [e-mail]; Website: www.hpcbiosciences.com	Abbreviated Name on BOLT System    HPC BIO	Scrip ID on BOLT System       HPCBL	ISIN No. INE507O01017
Issue Price: Rs. 35/- per share (Face Value of Rs.10/- and premium of Rs.25/-)		Date of Allotment in the public issue: March 14, 2013

1.    Trading Members may note that as per the guidelines issued by SEBI dated 16^th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e. 4000 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.

2.     The trading in the scrip shall continue  to remain in  Trade-for-Trade segment  till further notice since minimum of 50% of the  public shareholding of the company is not in demat form, as per extant SEBI guidelines.

3.     Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on March 19, 2013.For further information on SPOS, the trading members are requested to refer to the Exchange’s notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPO’s & Relisted Scrips.

4.    Trading Members may note that the shares bearing the distinctive numbers, the details of which are attached as Annexure I, are not transferable till the date(s) mentioned against them and would not be a good delivery in the market till then. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records.

5.     A copy of shareholding pattern submitted by the company is enclosed as Annexure II.

6.     The company’s financial year ending is March 31.

6.     All shares are ranking pari-passu including dividend entitlement.

7.    The Market Maker to the issue as mentioned in the prospectus is given below:

                          Narayan Securities Ltd.

E-1/7, III Floor, East Patel Nagar,

Delhi-110008

Tel : [phone]

Fax: [phone]

Email: [e-mail]

Website: www.narayanonline.com

Contact Person: Mr. Pawan Bhararia

SEBI Regn. No: INB 010935436

Market Maker Registration No. SMEMM0323309052012

8.    The Registrar to the issue as mentioned in the prospectus is given below:

Cameo Corporate Services Ltd.

Subramanian Building,

1 Club House Road, Chennai 600 002.

Tel No.: [phone]/1989

Fax No.: [phone]

E-mail ID: [e-mail]

Website: www.cameoindia.com

9.     In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:

a) At the company: Mr. Avinash Kumar Singh, Company Secretary & Compliance Officer	Registered Office of the Company: 6 A, 40, Hanuman Road, Connaught Place, New Delhi-110 001 Tel: [phone] Fax: [phone] Email: [e-mail]; Website: www.hpcbiosciences.com
b) At the Exchange: Nitinkumar Pujari     Manager	Tel.: (91) 022 22728398

Bhushan Mokashi

Asst. General Manager

Monday, March 18, 2013